Clinical Trial
doi: 10.1016/j.amjcard.2003.09.018.
Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl
Affiliations
- PMID: 14697473
- DOI: 10.1016/j.amjcard.2003.09.018
Item in Clipboard
Clinical Trial
Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl
Am J Cardiol.
.
Abstract
The effect of 6-week treatment with 80 mg/day atorvastatin on vascular function in the forearm was investigated in 18 patients with mean pretreatment serum low-density lipoprotein cholesterol concentrations of 112 +/- 4 mg/dl in a double-blind, placebo-controlled, randomized study. Statin treatment improved hyperemic forearm blood flow and decreased serum markers of oxidative stress and inflammation.
Similar articles
-
Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.Am J Cardiol. 2002 Oct 1;90(7):747-50. doi: 10.1016/s0002-9149(02)02602-4. Am J Cardiol. 2002. PMID: 12356389 Clinical Trial.
-
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.Am J Cardiol. 2002 Feb 1;89(3):268-75. doi: 10.1016/s0002-9149(01)02226-3. Am J Cardiol. 2002. PMID: 11809427 Clinical Trial.
-
Effect of atorvastatin on impaired vascular function in healthy old men.J Clin Pharm Ther. 2004 Apr;29(2):157-64. doi: 10.1111/j.1365-2710.2004.00548.x. J Clin Pharm Ther. 2004. PMID: 15068405
-
Lipitor (atorvastatin calcium) tablets.Gastroenterol Nurs. 1998 Sep-Oct;21(5):219-20. doi: 10.1097/00001610-199809000-00008. Gastroenterol Nurs. 1998. PMID: 9830966 Review. No abstract available.
-
Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia.Vasc Health Risk Manag. 2010 Nov 2;6:997-1005. doi: 10.2147/VHRM.S7802. Vasc Health Risk Manag. 2010. PMID: 21127702 Free PMC article. Review.
Cited by
-
Endothelial function as a functional expression of cardiovascular risk factors.Biomark Med. 2010 Jun;4(3):351-60. doi: 10.2217/bmm.10.61. Biomark Med. 2010. PMID: 20550469 Free PMC article. Review.
-
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration.Biochem Med (Zagreb). 2012;22(1):39-48. doi: 10.11613/bm.2012.005. Biochem Med (Zagreb). 2012. PMID: 22384518 Free PMC article. Review.
-
Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management.Drugs. 2008;68(7):885-900. doi: 10.2165/00003495-200868070-00001. Drugs. 2008. PMID: 18457457 Review.
-
Adjunctive interventions in myocardial infarction: the role of statin therapy.Curr Atheroscler Rep. 2008 Apr;10(2):142-8. doi: 10.1007/s11883-008-0021-3. Curr Atheroscler Rep. 2008. PMID: 18417069 Review.
-
Cardiovascular effects of resveratrol and atorvastatin treatments in an H2O2-induced stress model.Exp Ther Med. 2014 Nov;8(5):1660-1664. doi: 10.3892/etm.2014.1956. Epub 2014 Sep 11. Exp Ther Med. 2014. PMID: 25289077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
